An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The ...

Medication options are available to help manage the cognitive and behavioral symptoms of dementia and Alzheimer's disease.

The company has partnered with Nvidia to develop “cognitive AI,” which it says will allow people with severe physical ...

AI analysis of mental health queries shows rising self-diagnosis, cognitive decline, polarization, and radicalization, ...

A stem cell therapy trial aimed at reducing neuroinflammation in patients with presymptomatic Alzheimer's disease is underway at UTHealth Houston.